Member news

PrecisionLife has been awarded a €2.5m non-dilutive grant by the European Innovation Council (EIC) for its TRANSCEND project, to more rapidly and accurately triage and treat patients with endometriosis.

Stablepharma Ltd has secured a €2.5 million EIC Accelerator grant, recognizing its pioneering fridge-free pharmaceutical technology.

Axplora unveils a €50 million investment at its Mourenx site, strengthening its role in producing next-generation therapies, including GLP-1 drugs for diabetes and obesity.

Isomorphic Labs has expanded its strategic collaboration with Novartis, adding up to three new research programs to accelerate AI-driven drug discovery. This deepened partnership underscores the transformative potential of AI in tackling some of the most challenging targets in medicine.

GitLife Biotech and Colorifix have partnered to enhance traceability and scalability in eco-friendly textile dyeing. The project is supported by Innovate UK.

Unlike conventional approaches, AbDrop™ directly screens naturally matured individual B cells, maximizing CDR diversity by mining the entire plasma cell repertoire. This high-throughput system enables rapid identification of natively paired sequences, significantly reducing the discovery timeline to just 2–3 months.

Intelligent upgrade of existing, purpose-built laboratory spaces will be available for occupation from Q3, 2025.

Eleven early-stage companies working in oncology have started ‘Discovery Spark’, a free seven week development programme hosted by leading science and innovation campus Discovery Park, in Sandwich, Kent.

Melio Bio, a biotech dedicated to the discovery and development of novel inhibitors targeting a receptor implicated in obesity and associated co-morbidities, has been revealed as the winner of Pioneer Group and Novo Nordisk’s 2025 Golden Ticket Programme.

Coulter Partners successfully completed a search assignment for Bausch Health Companies and is pleased to announce the placement of Jonathan Sadeh M.D., M.Sc., as Executive Vice President, Chief Medical Officer and Head of R&D.

A new network will foster collaboration among regulators, industry, and researchers to ensure there is a world-leading regulatory environment in the UK for advanced therapies that supports companies in the development, trial, and launch of these innovative treatments.

Prostate cancer is the most common cancer among men, with over 136 new diagnoses in the UK each day. Stratosvir, a leading company in viral immunotherapy, is changing the landscape of treatment.

Pioneer Group, a leader in life science infrastructure and venture-building, has appointed industry leader, Chris Walters, as Portfolio Director and European Acquisitions Lead.

Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline.

This latest research builds upon the growing body of evidence demonstrating the unique impact of Brainomix’s AI-powered software to expand access to life-changing stroke treatments across networks.

Myricx Bio (‘Myricx’) announces that Paolo Paoletti, MD, has joined its Board of Directors as an independent Non-Executive Director (NED).

Coulter Partners successfully completed a search assignment for Our Future Health and is pleased to announce the placement of Andrew Miles, as Chief Business Officer (CBO).

Precision BioSearch is proud to support the Pioneer Group Launch Accelerator Programme for the second consecutive year, equipping the UK and Ireland’s most promising biotech founders with the skills to build and scale high-performing teams.

Precision BioSearch was delighted to partner with Optieum Biotechnologies Inc. (“Optieum”), a biotechnology company focused on discovering and developing innovative CAR-T cell therapies, to secure the appointment of Dr. Dan MacLeod as Chief Scientific Officer.

The Institute of Clinical Research (ICR) is proud to now be a Networking Member of the BIA.